Literature DB >> 2681847

The return of acute rheumatic fever in young adults.

M R Wallace1, P D Garst, T J Papadimos, E C Oldfield.   

Abstract

The incidence of acute rheumatic fever (ARF) in the United States has been steadily declining for three decades, and by the mid-1980s had virtually disappeared. In the past 3 years, however, several scattered outbreaks have occurred among US schoolchildren, and there is speculation that ARF will again become a major public health problem in North America. We report a clustering of 10 cases of ARF in young men undergoing basic training at a recruit camp in San Diego, Calif. This was the first such outbreak in two decades among US military personnel and the largest reported series of ARF cases among adults in more than a decade in the United States. Adult-onset ARF was not benign in our patients. The rate of carditis (3 of 10 patients) was similar to that in older studies of adults with ARF. All patients in our series suffered severe polyarthritis, anemia, and fever, but only 60% gave any history of preceding pharyngitis. Rheumatic fever must again be suspected in adults, as well as children, who present with polyarthritis.

Entities:  

Mesh:

Year:  1989        PMID: 2681847

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  16 in total

1.  National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sites.

Authors:  Christopher P Barrozo; Kevin L Russell; Tyler C Smith; Anthony W Hawksworth; Margaret A K Ryan; Gregory C Gray
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  Rheumatic fever: changes in its incidence and presentation.

Authors:  T Vyse
Journal:  BMJ       Date:  1991-03-02

Review 3.  Reconsidering sore throats. Part I: Problems with current clinical practice.

Authors:  W J McIsaac; V Goel; P M Slaughter; G W Parsons; K V Woolnough; P T Weir; J R Ennet
Journal:  Can Fam Physician       Date:  1997-03       Impact factor: 3.275

Review 4.  Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity.

Authors:  Soumya D Chakravarty; John B Zabriskie; Allan Gibofsky
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

5.  Prevalence of rheumatic heart disease in Senegalese school children: a clinical and echocardiographic screening.

Authors:  Aliou Alassane Ngaïdé; Alassane Mbaye; Adama Kane; Mouhamadou Bamba Ndiaye; Modou Jobe; Malick Bodian; Momar Dioum; Simon Antoine Sarr; Fatou Aw; Prisca Sede Mbakop; Fatimata Gatta Ba; Ngoné Diaba Gaye; Alioune Tabane; Mamadou Bassirou Bah; Sarah Mouna Coly; Dior Diagne; Bouna Diack; Maboury Diao; Abdoul Kane
Journal:  Heart Asia       Date:  2015-11-30

6.  A clinical score to reduce unnecessary antibiotic use in patients with sore throat.

Authors:  W J McIsaac; D White; D Tannenbaum; D E Low
Journal:  CMAJ       Date:  1998-01-13       Impact factor: 8.262

7.  Treatment of streptococcal pharyngitis with amoxycillin once a day.

Authors:  P Shvartzman; H Tabenkin; A Rosentzwaig; F Dolginov
Journal:  BMJ       Date:  1993-05-01

Review 8.  Beta haemolytic streptococci and reactive arthritis in adults.

Authors:  C Deighton
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

9.  Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome.

Authors:  D F Talkington; B Schwartz; C M Black; J K Todd; J Elliott; R F Breiman; R R Facklam
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Inference of antibiotic resistance and virulence among diverse group A Streptococcus strains using emm sequencing and multilocus genotyping methods.

Authors:  David Metzgar; Darcie Baynes; Christian J Hansen; Erin A McDonough; Daisy R Cabrera; Melody M Ellorin; Patrick J Blair; Kevin L Russell; Dennis J Faix
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.